B, F., M, M., K, S., T, W., A, D., A, G., & M, D. H. (2011). The METEOR study: Frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs. International clinical psychopharmacology, 26(6), 291. https://doi.org/10.1097/YIC.0b013e32834a5bf6
Chicago Style (17th ed.) CitationB, Falissard, Mauri M, Shaw K, Wetterling T, Doble A, Giudicelli A, and De Hert M. "The METEOR Study: Frequency of Metabolic Disorders in Patients with Schizophrenia. Focus on First and Second Generation and Level of Risk of Antipsychotic Drugs." International Clinical Psychopharmacology 26, no. 6 (2011): 291. https://doi.org/10.1097/YIC.0b013e32834a5bf6.
MLA (9th ed.) CitationB, Falissard, et al. "The METEOR Study: Frequency of Metabolic Disorders in Patients with Schizophrenia. Focus on First and Second Generation and Level of Risk of Antipsychotic Drugs." International Clinical Psychopharmacology, vol. 26, no. 6, 2011, p. 291, https://doi.org/10.1097/YIC.0b013e32834a5bf6.